Current Neuro-Oncology

Volume 5 Number 1
31 January 2002

Home > Publications > Current Neuro-Oncology > Volume 5, Year 2003 > Number 1, 31 January

Lutterbach J, Sauerbrei W, Guttenberger R.
Multivariate analysis of prognostic factors in patients with glioblastoma.
Strahlenther Onkol. 2003 Jan;179(1):8-15. doi: 10.1007/s00066-003-1004-5. PMID: 12540979. Observational study.

Murphy M, Timms C, McKelvie P, Dowling A, Trost N.
Malignant optic nerve glioma: metastases to the spinal neuraxis. Case illustration.
J Neurosurg Spine. 2003 Jan;98(1 Suppl):110. doi: 10.3171/spi.2003.98.1.0110. PMID: 12546402∟. Case report.

Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Poulsen HS, Müller J.
A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor.
J Clin Endocrinol Metab. 2003 Jan 1;88(1):136-40. doi: 10.1210/jc.2002-020380. PMID: 12519842. Observational study.

Vuorinen V, Hinkka S, Färkkilä M, Jääskeläinen J.
Debulking or biopsy of malignant glioma in elderly people - a randomised study.
Acta Neurochir (Wien).
2003 Jan 14;145(1):5-10. doi: 10.1007/s00701-002-1030-6. PMID: 12545256. Interventional study. ˍ

Buckner JC, Gesme D Jr, O'Fallon JR, Hammack JE, Stafford S, Brown PD, Hawkins R, Scheithauer BW, Erickson BJ, Levitt R, Shaw EG, Jenkins R.
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
J Clin Oncol. 2003 Jan 15;21(2):251-5. doi: 10.1200/JCO.2003.06.023. PMID: 12525516. Interventional study.

Panasci L, Stinson SF, Melnychuk D, Sandor V, Miller WH Jr, Batist G, Patenaude F, Bangash N, Panarello L, Alaoui-Jamali M, Sausville E.
SarCNU, a nitrosourea analog on a day 1, 5, and 9 oral schedule: a phase I and pharmacokinetic study in patients with advanced solid tumors.
J Clin Oncol. 2003 Jan 15;21(2):232-40. doi: 10.1200/JCO.2003.03.047. PMID: 12525514. Interventional study.